Posted On: 09/24/2014 10:35:29 AM
Post# of 72747
$ARIA Recent Headlines
Six stocks to watch
4:27 p.m. Feb. 26, 2014
- The Trading Deck
6 stocks to watch
4:34 p.m. Feb. 12, 2014
- The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains
10:02 p.m. Jan. 27, 2014
- Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers
4:42 p.m. Jan. 27, 2014
- Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover
2:43 p.m. Jan. 24, 2014
- Russ Britt
5 charts to watch
4:52 p.m. Jan. 15, 2014
- The Trading Deck
Apple closes lower; B. of A. rises on analyst call
5:15 p.m. Jan. 2, 2014
- Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally
4:33 p.m. Dec. 23, 2013
- Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug
7:33 a.m. Dec. 23, 2013
- MarketWatch.com
J.C. Penney and more of the year's most profitable shorts
4:23 p.m. Dec. 9, 2013
- blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble
9:50 a.m. Nov. 26, 2013
- Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled
1:14 p.m. Oct. 31, 2013
- Russ Britt
H-P has best day in four months on upbeat outlook
4:34 p.m. Oct. 9, 2013
- Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues
11:38 a.m. Oct. 9, 2013
- Russ Britt
FDA places partial hold on Ariad's Iclusig trials
8:16 a.m. Oct. 9, 2013
- MarketWatch.com
Dan Loeb makes bet on Disney
8:06 p.m. Aug. 14, 2013
- David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs
11:33 a.m. July 1, 2013
- Russ Britt
SAC Capital Advisors likes this pharma stock
4:24 p.m. April 18, 2013
- Insider Monkey
Ariad Pharma up 6% to $20.09
11:35 a.m. Dec. 17, 2012
- Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia
2:06 p.m. Dec. 14, 2012
- MarketWatch.com
Amgen Files Blinatumomab Marketing Application in U.S. - Analyst Blog
5:55 p.m. Sept. 23, 2014
- Zacks.com
Ariad Director Resignation May Mean CEO Berger One Step Closer to Exit
12:05 p.m. Sept. 19, 2014
- TheStreet.com
InsiderInsights.com Daily Round Up 9/11/14: LULU, ARIA, TITN, RSG
9:58 a.m. Sept. 12, 2014
- Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ISIS ARIA ACAD ALNY
8:00 a.m. Sept. 12, 2014
- InvestorPlace.com
Biotech Stock Mailbag: Achillion, Ariad Revisited, Endocyte
8:55 a.m. Sept. 5, 2014
- TheStreet.com
Biggest Movers in Healthcare Stocks Now – CLDX ARIA CNC ZMH
7:45 a.m. Sept. 4, 2014
- InvestorPlace.com
'Mad Money' Lightning Round: Yahoo! Is One of the Best Buys Around
6:00 a.m. Sept. 4, 2014
- TheStreet.com
Cramer's Lightning Round - Yahoo Is A Good Steward Of Capital (9/3/14)
5:40 a.m. Sept. 4, 2014
- Seeking Alpha
Jim Cramer's 'Mad Money' Recap: These Are 3 Stocks Cramer Trusts
8:17 p.m. Sept. 3, 2014
- TheStreet.com
Biggest Movers in Healthcare Stocks Now – CYH ARIA THC LUX
8:15 a.m. Aug. 29, 2014
- InvestorPlace.com
Biotechs With Insider Buying
2:16 p.m. Aug. 22, 2014
- Seeking Alpha
Hottest Healthcare Stocks Now – ARIA CELG LCI RDY
9:15 a.m. Aug. 20, 2014
- InvestorPlace.com
InsiderInsights.com Daily Round Up: 8/19/14
3:36 a.m. Aug. 20, 2014
- Seeking Alpha
Hottest Healthcare Stocks Now – PTCT LGND WX BIIB
1:45 p.m. Aug. 15, 2014
- InvestorPlace.com
ARIAD Falls on Wider-than-Expected Loss, Revenues Miss - Analyst Blog
12:21 p.m. Aug. 11, 2014
- Zacks.com
Ariad Pharmaceuticals' (ARIA) CEO Harvey Berger on Q2 2014 Results - Earnings Call Transcript
5:30 p.m. Aug. 6, 2014
- Seeking Alpha
Why Ariad Pharmaceuticals (ARIA) Stock Is Down Today
1:07 p.m. Aug. 6, 2014
- TheStreet.com
Ariad updates guidance after Q2 results
8:51 a.m. Aug. 6, 2014
- Seeking Alpha
ARIAD Pharmaceuticals (ARIA) Q2 2014 Results - Earnings Call Webcast
8:25 a.m. Aug. 6, 2014
- Seeking Alpha
Notable earnings before Wednesday’s open
5:30 p.m. Aug. 5, 2014
- Seeking Alpha
INNATE PHARMA APPOINTS PIERRE DODION AS CHIEF MEDICAL OFFICER AND MEMBER OF THE EXECUTIVE COMMITTEE
12:41 p.m. Sept. 16, 2014
- GlobeNewswire
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen
8:55 a.m. Sept. 4, 2014
- PR Newswire - PRF
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024
1:19 p.m. Aug. 19, 2014
- PR Newswire - PRF
ARIAD Reports Second Quarter 2014 Financial Results and Development
Progress
11:34 p.m. Aug. 6, 2014
- BusinessWire - BZX
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel
7:36 a.m. Aug. 5, 2014
- BusinessWire - BZX
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma
9:00 a.m. Aug. 1, 2014
- PR Newswire - PRF
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial
Results
7:35 a.m. July 16, 2014
- BusinessWire - BZX
ARIAD Announces Continuation of Iclusig Review under the Article 20
Procedure in Europe
7:35 a.m. July 14, 2014
- BusinessWire - BZX
Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics
5:00 a.m. June 27, 2014
- PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics
7:30 a.m. June 26, 2014
- PR Newswire - PRF
ARIAD Announces Three Key Appointments to Its Global Management Team
7:35 a.m. June 23, 2014
- BusinessWire - BZX
ARIAD Announces Pricing of $200 Million Offering of 3.625%
Convertible Senior Notes Due 2019
9:15 a.m. June 12, 2014
- BusinessWire - BZX
ARIAD Announces Proposed $175 Million Offering of Convertible Senior
Notes Due 2019
4:01 p.m. June 11, 2014
- BusinessWire - BZX
ARIAD Announces Webcast of Its Annual Shareholders Meeting
7:35 a.m. June 11, 2014
- BusinessWire - BZX
Cohera Medical, Inc.® Appoints Richard W. Pascoe to its Board of Directors
6:00 a.m. June 4, 2014
- PR Newswire - PRF
ARIAD Announces Initial Data from Phase 2 Trial of Ponatinib in
Patients with Gastrointestinal Stromal Tumors
9:01 a.m. June 1, 2014
- BusinessWire - BZX
ARIAD Presents Updated Phase 1/2 Data on AP26113
in Patients with ALK+ Non-Small Cell Lung Cancer
2:16 p.m. May 31, 2014
- BusinessWire - BZX
Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron
7:10 a.m. May 30, 2014
- PR Newswire - PRF
ARIAD to Present at Upcoming Investor Conferences
7:36 a.m. May 28, 2014
- BusinessWire - BZX
Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology
7:40 a.m. May 20, 2014
- PR Newswire - PRF
Six stocks to watch
4:27 p.m. Feb. 26, 2014
- The Trading Deck
6 stocks to watch
4:34 p.m. Feb. 12, 2014
- The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains
10:02 p.m. Jan. 27, 2014
- Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers
4:42 p.m. Jan. 27, 2014
- Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover
2:43 p.m. Jan. 24, 2014
- Russ Britt
5 charts to watch
4:52 p.m. Jan. 15, 2014
- The Trading Deck
Apple closes lower; B. of A. rises on analyst call
5:15 p.m. Jan. 2, 2014
- Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally
4:33 p.m. Dec. 23, 2013
- Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug
7:33 a.m. Dec. 23, 2013
- MarketWatch.com
J.C. Penney and more of the year's most profitable shorts
4:23 p.m. Dec. 9, 2013
- blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble
9:50 a.m. Nov. 26, 2013
- Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled
1:14 p.m. Oct. 31, 2013
- Russ Britt
H-P has best day in four months on upbeat outlook
4:34 p.m. Oct. 9, 2013
- Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues
11:38 a.m. Oct. 9, 2013
- Russ Britt
FDA places partial hold on Ariad's Iclusig trials
8:16 a.m. Oct. 9, 2013
- MarketWatch.com
Dan Loeb makes bet on Disney
8:06 p.m. Aug. 14, 2013
- David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs
11:33 a.m. July 1, 2013
- Russ Britt
SAC Capital Advisors likes this pharma stock
4:24 p.m. April 18, 2013
- Insider Monkey
Ariad Pharma up 6% to $20.09
11:35 a.m. Dec. 17, 2012
- Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia
2:06 p.m. Dec. 14, 2012
- MarketWatch.com
Amgen Files Blinatumomab Marketing Application in U.S. - Analyst Blog
5:55 p.m. Sept. 23, 2014
- Zacks.com
Ariad Director Resignation May Mean CEO Berger One Step Closer to Exit
12:05 p.m. Sept. 19, 2014
- TheStreet.com
InsiderInsights.com Daily Round Up 9/11/14: LULU, ARIA, TITN, RSG
9:58 a.m. Sept. 12, 2014
- Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ISIS ARIA ACAD ALNY
8:00 a.m. Sept. 12, 2014
- InvestorPlace.com
Biotech Stock Mailbag: Achillion, Ariad Revisited, Endocyte
8:55 a.m. Sept. 5, 2014
- TheStreet.com
Biggest Movers in Healthcare Stocks Now – CLDX ARIA CNC ZMH
7:45 a.m. Sept. 4, 2014
- InvestorPlace.com
'Mad Money' Lightning Round: Yahoo! Is One of the Best Buys Around
6:00 a.m. Sept. 4, 2014
- TheStreet.com
Cramer's Lightning Round - Yahoo Is A Good Steward Of Capital (9/3/14)
5:40 a.m. Sept. 4, 2014
- Seeking Alpha
Jim Cramer's 'Mad Money' Recap: These Are 3 Stocks Cramer Trusts
8:17 p.m. Sept. 3, 2014
- TheStreet.com
Biggest Movers in Healthcare Stocks Now – CYH ARIA THC LUX
8:15 a.m. Aug. 29, 2014
- InvestorPlace.com
Biotechs With Insider Buying
2:16 p.m. Aug. 22, 2014
- Seeking Alpha
Hottest Healthcare Stocks Now – ARIA CELG LCI RDY
9:15 a.m. Aug. 20, 2014
- InvestorPlace.com
InsiderInsights.com Daily Round Up: 8/19/14
3:36 a.m. Aug. 20, 2014
- Seeking Alpha
Hottest Healthcare Stocks Now – PTCT LGND WX BIIB
1:45 p.m. Aug. 15, 2014
- InvestorPlace.com
ARIAD Falls on Wider-than-Expected Loss, Revenues Miss - Analyst Blog
12:21 p.m. Aug. 11, 2014
- Zacks.com
Ariad Pharmaceuticals' (ARIA) CEO Harvey Berger on Q2 2014 Results - Earnings Call Transcript
5:30 p.m. Aug. 6, 2014
- Seeking Alpha
Why Ariad Pharmaceuticals (ARIA) Stock Is Down Today
1:07 p.m. Aug. 6, 2014
- TheStreet.com
Ariad updates guidance after Q2 results
8:51 a.m. Aug. 6, 2014
- Seeking Alpha
ARIAD Pharmaceuticals (ARIA) Q2 2014 Results - Earnings Call Webcast
8:25 a.m. Aug. 6, 2014
- Seeking Alpha
Notable earnings before Wednesday’s open
5:30 p.m. Aug. 5, 2014
- Seeking Alpha
INNATE PHARMA APPOINTS PIERRE DODION AS CHIEF MEDICAL OFFICER AND MEMBER OF THE EXECUTIVE COMMITTEE
12:41 p.m. Sept. 16, 2014
- GlobeNewswire
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen
8:55 a.m. Sept. 4, 2014
- PR Newswire - PRF
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024
1:19 p.m. Aug. 19, 2014
- PR Newswire - PRF
ARIAD Reports Second Quarter 2014 Financial Results and Development
Progress
11:34 p.m. Aug. 6, 2014
- BusinessWire - BZX
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel
7:36 a.m. Aug. 5, 2014
- BusinessWire - BZX
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma
9:00 a.m. Aug. 1, 2014
- PR Newswire - PRF
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial
Results
7:35 a.m. July 16, 2014
- BusinessWire - BZX
ARIAD Announces Continuation of Iclusig Review under the Article 20
Procedure in Europe
7:35 a.m. July 14, 2014
- BusinessWire - BZX
Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics
5:00 a.m. June 27, 2014
- PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics
7:30 a.m. June 26, 2014
- PR Newswire - PRF
ARIAD Announces Three Key Appointments to Its Global Management Team
7:35 a.m. June 23, 2014
- BusinessWire - BZX
ARIAD Announces Pricing of $200 Million Offering of 3.625%
Convertible Senior Notes Due 2019
9:15 a.m. June 12, 2014
- BusinessWire - BZX
ARIAD Announces Proposed $175 Million Offering of Convertible Senior
Notes Due 2019
4:01 p.m. June 11, 2014
- BusinessWire - BZX
ARIAD Announces Webcast of Its Annual Shareholders Meeting
7:35 a.m. June 11, 2014
- BusinessWire - BZX
Cohera Medical, Inc.® Appoints Richard W. Pascoe to its Board of Directors
6:00 a.m. June 4, 2014
- PR Newswire - PRF
ARIAD Announces Initial Data from Phase 2 Trial of Ponatinib in
Patients with Gastrointestinal Stromal Tumors
9:01 a.m. June 1, 2014
- BusinessWire - BZX
ARIAD Presents Updated Phase 1/2 Data on AP26113
in Patients with ALK+ Non-Small Cell Lung Cancer
2:16 p.m. May 31, 2014
- BusinessWire - BZX
Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron
7:10 a.m. May 30, 2014
- PR Newswire - PRF
ARIAD to Present at Upcoming Investor Conferences
7:36 a.m. May 28, 2014
- BusinessWire - BZX
Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology
7:40 a.m. May 20, 2014
- PR Newswire - PRF
(0)
(0)
